Medtronic's Resolute drug-eluting stent (DES) is as good as its market-leading rival, Abbott's Xience V, according to the first major head-to-head study of the two devices. The first results from the RESOLUTE All Comers study, presented at the annual EuroPCR meeting, held in Paris, ...
Please Login to read the full article.
